Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:20 PM
Ignite Modification Date:
2025-12-24 @ 10:20 PM
NCT ID:
NCT00180635
Eligibility Criteria:
Inclusion Criteria:
* Healthy non-smokers
* Normal spirometry (FEV1 \>90 % predicted; exhaled NO bigger than or equal to 10 ppb; flow 50 ml/s)
* At risk (current smokers)
* Normal spirometry, with or without chronic symptoms (cough, sputum production)
* FEV1 reversibility of \<15% after inhaled beta2-agonists\*
* Moderate COPD
* FEV1 greater than or equal to 30% and \< 80%
* FEV1/FVC \< 70% predicted
* FEV1 reversibility of \<15% after inhaled beta2-agonists
* With or without chronic symptoms (cough, sputum production, dyspnea)
* Able to comprehend and grant a written informed consent
Exclusion Criteria:
* Concomitant use or pre-treatment within the last 4 weeks with oral steroids
* Respiratory infection within 4 weeks prior to entry into the trial
* Females who are pregnant or lactating
* History of current or past drug or alcohol abuse
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
70 Years
Study:
NCT00180635
Study Brief:
Protocol Section:
NCT00180635